Francisco Partners to Acquire Weave for Approximately $650 Million - Summary - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Francisco Partners to Acquire Weave for Approximately $650 Million

Healthcare technology company would become privately held following completion of the transaction.

  • By

  • News Staff

  • August 25, 2026

Share

Objective:

To announce the acquisition of Weave Communications, Inc. by Francisco Partners.

Approach:
  • Acquisition Details: Weave has entered into a definitive agreement for acquisition by Francisco Partners with an equity valuation of approximately $650 million, offering Weave stockholders $7.40 per share in cash.
  • Premium Valuation: The purchase price represents a 34% premium over Weave’s stock price on August 17, 2026.
  • Operational Continuity: Post-acquisition, Weave will cease trading on the NYSE, remain under its name, and continue operations from Lehi, Utah.
  • Strategic Goals: Weave aims to enhance its AI platform and revenue cycle management capabilities in partnership with Francisco Partners.
  • Board Approval: Weave’s board unanimously approved the transaction after evaluating strategic alternatives.
  • Closing Timeline: The transaction is expected to close in Q4 2026, pending stockholder approval and regulatory approvals.
Key Findings:
  • Weave serves over 40,000 customer locations with its AI-powered patient engagement platform.
  • Francisco Partners has a history of successfully scaling companies in vertical software and healthcare.
Interpretation:

The acquisition is positioned as a strategic move to enhance Weave's capabilities in the healthcare technology sector.

Limitations:
  • No Weave executive has committed to roll over equity or invest alongside Francisco Partners.
Conclusion:

The acquisition represents a significant milestone for Weave, providing a pathway for continued growth and innovation in healthcare technology.

Sources:

Original Source(s)

Francisco Partners to Acquire Weave for Approximately $650 Million

  • by News Staff

  • August 25, 2026

Related Content

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

Former Dentist Ordered to Pay for Unlawful Prescribing

The judgment stemmed from controlled-substance prescriptions issued after William C. Gardner, DDS, no longer held the state licensure required for federal prescribing authority.

Changing Dental Practice Ownership Trends May Affect Succession Planning

A live webinar on August 27 will cover the dental market and practice-transition landscape.